Retrospective ANalysis of multi-drug resistant Gram-nEgative bacteRia on veno-venous extracorporeal membrane oxygenation. The multicenter RANGER STUDY.
ECMO
ESBL
Extended-spectrum beta-lactamase
Extracorporeal membrane oxygenation
MDR
MDRO
Multi-drug resistant
Journal
Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902
Informations de publication
Date de publication:
27 Aug 2024
27 Aug 2024
Historique:
received:
26
06
2024
accepted:
15
08
2024
medline:
28
8
2024
pubmed:
28
8
2024
entrez:
27
8
2024
Statut:
epublish
Résumé
Veno-venous extracorporeal membrane oxygenation (V-V ECMO) is a rapidly expanding life-support technique worldwide. The most common indications are severe hypoxemia and/or hypercapnia, unresponsive to conventional treatments, primarily in cases of acute respiratory distress syndrome. Concerning potential contraindications, there is no mention of microbiological history, especially related to multi-drug resistant (MDR) bacteria isolated before V-V ECMO placement. Our study aims to investigate: (i) the prevalence and incidence of MDR Gram-negative (GN) bacteria in a cohort of V-V ECMOs; (ii) the risk of 1-year mortality, especially in the case of predetected MDR GN bacteria; and (iii) the impact of annual hospital V-V ECMO volume on the probability of acquiring MDR GN bacteria. All consecutive adults admitted to the Intensive Care Units of 5 Italian university-affiliated hospitals and requiring V-V ECMO were screened. Exclusion criteria were age < 18 years, pregnancy, veno-arterial or mixed ECMO-configuration, incomplete records, survival < 24 h after V-V ECMO. A standard protocol of microbiological surveillance was applied and MDR profiles were identified using in vitro susceptibility tests. Cox-proportional hazards models were applied for investigating mortality. Two hundred and seventy-nine V-V ECMO patients (72% male) were enrolled. The overall MDR GN bacteria percentage was 50%: 21% (n.59) detected before and 29% (n.80) after V-V ECMO placement. The overall 1-year mortality was 42%, with a higher risk observed in predetected patients (aHR 2.14 [1.33-3.47], p value 0.002), while not in 'V-V ECMO-acquired MDR GN bacteria' group (aHR 1.51 [0.94-2.42], p value 0.090), as compared to 'non-MDR GN bacteria' group (reference). Same findings were found considering only infections. A larger annual hospital V-V ECMO volume was associated with a lower probability of acquiring MDR GN bacteria during V-V ECMO course (aOR 0.91 [0.86-0.97], p value 0.002). 21% of MDR GN bacteria were detected before; while 29% after V-V ECMO connection. A history of MDR GN bacteria, isolated before V-V ECMO, was an independent risk factor for mortality. The annual hospital V-V ECMO volume affected the probability of acquiring MDR GN bacteria. Trial Registration ClinicalTrial.gov Registration Number NCTNCT06199141, date 12.26.2023.
Sections du résumé
BACKGROUND
BACKGROUND
Veno-venous extracorporeal membrane oxygenation (V-V ECMO) is a rapidly expanding life-support technique worldwide. The most common indications are severe hypoxemia and/or hypercapnia, unresponsive to conventional treatments, primarily in cases of acute respiratory distress syndrome. Concerning potential contraindications, there is no mention of microbiological history, especially related to multi-drug resistant (MDR) bacteria isolated before V-V ECMO placement. Our study aims to investigate: (i) the prevalence and incidence of MDR Gram-negative (GN) bacteria in a cohort of V-V ECMOs; (ii) the risk of 1-year mortality, especially in the case of predetected MDR GN bacteria; and (iii) the impact of annual hospital V-V ECMO volume on the probability of acquiring MDR GN bacteria.
METHODS
METHODS
All consecutive adults admitted to the Intensive Care Units of 5 Italian university-affiliated hospitals and requiring V-V ECMO were screened. Exclusion criteria were age < 18 years, pregnancy, veno-arterial or mixed ECMO-configuration, incomplete records, survival < 24 h after V-V ECMO. A standard protocol of microbiological surveillance was applied and MDR profiles were identified using in vitro susceptibility tests. Cox-proportional hazards models were applied for investigating mortality.
RESULTS
RESULTS
Two hundred and seventy-nine V-V ECMO patients (72% male) were enrolled. The overall MDR GN bacteria percentage was 50%: 21% (n.59) detected before and 29% (n.80) after V-V ECMO placement. The overall 1-year mortality was 42%, with a higher risk observed in predetected patients (aHR 2.14 [1.33-3.47], p value 0.002), while not in 'V-V ECMO-acquired MDR GN bacteria' group (aHR 1.51 [0.94-2.42], p value 0.090), as compared to 'non-MDR GN bacteria' group (reference). Same findings were found considering only infections. A larger annual hospital V-V ECMO volume was associated with a lower probability of acquiring MDR GN bacteria during V-V ECMO course (aOR 0.91 [0.86-0.97], p value 0.002).
CONCLUSIONS
CONCLUSIONS
21% of MDR GN bacteria were detected before; while 29% after V-V ECMO connection. A history of MDR GN bacteria, isolated before V-V ECMO, was an independent risk factor for mortality. The annual hospital V-V ECMO volume affected the probability of acquiring MDR GN bacteria. Trial Registration ClinicalTrial.gov Registration Number NCTNCT06199141, date 12.26.2023.
Identifiants
pubmed: 39192287
doi: 10.1186/s13054-024-05068-x
pii: 10.1186/s13054-024-05068-x
doi:
Banques de données
ClinicalTrials.gov
['NCT06199141']
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
279Informations de copyright
© 2024. The Author(s).
Références
Tonna JE, Abrams D, Brodie D, Greenwood JC, Rubio Mateo-Sidron JA, Usman A, et al. Management of adult patients supported with venovenous extracorporeal membrane oxygenation (VV ECMO): guideline from the extracorporeal life support organization (ELSO). ASAIO J Am Soc Artif Intern Organs. 2021;67(6):601–10.
Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315(8):788–800.
pubmed: 26903337
doi: 10.1001/jama.2016.0291
Grasselli G, Calfee CS, Camporota L, Poole D, Amato MBP, Antonelli M, et al. ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies. Intensive Care Med Intensive Care Med. 2023;49(7):727–59.
pubmed: 37326646
doi: 10.1007/s00134-023-07050-7
Definition Task Force ARDS, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526–33.
Tonna JE, Boonstra PS, MacLaren G, Paden M, Brodie D, Anders M, et al. Extracorporeal life support organization registry international report 2022: 100,000 Survivors. ASAIO J. 2024;70(2):131–43.
pubmed: 38181413
Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet Lond Engl. 2009;374(9698):1351–63.
doi: 10.1016/S0140-6736(09)61069-2
Sella N, Pettenuzzo T, Zarantonello F, Andreatta G, De Cassai A, Schiavolin C, et al. Electrical impedance tomography: a compass for the safe route to optimal PEEP. Respir Med. 2021;187: 106555.
pubmed: 34352563
doi: 10.1016/j.rmed.2021.106555
Brodie D, Bacchetta M. Extracorporeal membrane oxygenation for ARDS in adults. N Engl J Med. 2011;365(20):1905–14.
pubmed: 22087681
doi: 10.1056/NEJMct1103720
Biffi S, Di Bella S, Scaravilli V, Peri AM, Grasselli G, Alagna L, et al. Infections during extracorporeal membrane oxygenation: epidemiology, risk factors, pathogenesis and prevention. Int J Antimicrob Agents. 2017;50(1):9–16.
pubmed: 28528989
doi: 10.1016/j.ijantimicag.2017.02.025
Schmidt M, Bailey M, Sheldrake J, Hodgson C, Aubron C, Rycus PT, et al. Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The respiratory extracorporeal membrane oxygenation survival prediction (RESP) score. Am J Respir Crit Care Med. 2014;189(11):1374–82.
pubmed: 24693864
doi: 10.1164/rccm.201311-2023OC
Menaker J, Galvagno S, Rabinowitz R, Penchev V, Hollis A, Kon Z, et al. Epidemiology of blood stream infection in adult extracorporeal membrane oxygenation patients: a cohort study. Heart Lung. 2019;48(3):236–9.
pubmed: 30686618
doi: 10.1016/j.hrtlng.2019.01.004
Yang L, Li M, Gu S, Feng Y, Huang X, Zhang Y, et al. Risk factors for bloodstream infection (BSI) in patients with severe acute respiratory distress syndrome (ARDS) supported by veno-venous extracorporeal membrane oxygenation (VV-ECMO). BMC Pulm Med. 2022;22(1):370.
pubmed: 36171599
pmcid: 9518943
doi: 10.1186/s12890-022-02164-y
Paul M, Carrara E, Retamar P, Tängdén T, Bitterman R, Bonomo RA, et al. European society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2022;28(4):521–47.
Rossolini GM, Bochenska M, Fumagalli L, Dowzicky M. Trends of major antimicrobial resistance phenotypes in enterobacterales and gram-negative non-fermenters from ATLAS and EARS-net surveillance systems: Italian vs. European and global data, 2008–2018. Diagn Microbiol Infect Dis. 2021;101(4): 115512.
pubmed: 34419741
doi: 10.1016/j.diagmicrobio.2021.115512
Tiseo G, Brigante G, Giacobbe DR, Maraolo AE, Gona F, Falcone M, et al. Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM). Int J Antimicrob Agents. 2022;60(2): 106611.
pubmed: 35697179
doi: 10.1016/j.ijantimicag.2022.106611
Grasselli G, Scaravilli V, Mangioni D, Scudeller L, Alagna L, Bartoletti M, et al. Hospital-acquired infections in critically ill patients with COVID-19. Chest. 2021;160(2):454–65.
pubmed: 33857475
doi: 10.1016/j.chest.2021.04.002
Grasselli G, Scaravilli V, Di Bella S, Biffi S, Bombino M, Patroniti N, et al. Nosocomial infections during extracorporeal membrane oxygenation: incidence, etiology, and impact on patients’ outcome. Crit Care Med. 2017;45(10):1726–33.
pubmed: 28777198
doi: 10.1097/CCM.0000000000002652
Azim A, Dwivedi M, Rao PB, Baronia AK, Singh RK, Prasad KN, et al. Epidemiology of bacterial colonization at intensive care unit admission with emphasis on extended-spectrum beta-lactamase- and metallo-beta-lactamase-producing Gram-negative bacteria–an Indian experience. J Med Microbiol. 2010;59(Pt 8):955–60.
pubmed: 20413621
doi: 10.1099/jmm.0.018085-0
Barbier F, Bailly S, Schwebel C, Papazian L, Azoulay É, Kallel H, et al. Infection-related ventilator-associated complications in ICU patients colonised with extended-spectrum β-lactamase-producing Enterobacteriaceae. Intensive Care Med. 2018;44(5):616–26.
pubmed: 29663045
doi: 10.1007/s00134-018-5154-4
Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious diseases society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections. Clin Infect Dis. 2023. https://doi.org/10.1093/cid/ciad428 .
doi: 10.1093/cid/ciad428
pubmed: 37843118
pmcid: 11004946
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10): e296.
doi: 10.1371/journal.pmed.0040296
Klompas M, Branson R, Cawcutt K, Crist M, Eichenwald EC, Greene LR, et al. Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol. 2022;43(6):687–713.
pubmed: 35589091
pmcid: 10903147
doi: 10.1017/ice.2022.88
Pickens CI, Wunderink RG. Principles and practice of antibiotic stewardship in the ICU. Chest. 2019;156(1):163–71.
pubmed: 30689983
pmcid: 7118241
doi: 10.1016/j.chest.2019.01.013
Boscolo A, Sella N, Pettenuzzo T, De Cassai A, Crociani S, Schiavolin C, et al. Multidrug-resistant and extended-spectrum β-lactamase gram-negative bacteria in bilateral lung transplant recipients: incidence, risk factors, and in-hospital mortality. Chest. 2022;162(6):1255–64.
pubmed: 35850288
doi: 10.1016/j.chest.2022.06.046
Paling FP, Wolkewitz M, Bode LGM, Klein Klouwenberg PMC, Ong DSY, Depuydt P, de Bus L, Sifakis F, Bonten MJM, Kluytmans JAJW. Staphylococcus aureus colonization at ICU admission as a risk factor for developing S. aureus ICU pneumonia. Clin Microbiol Infect. 2017;23(1):49.e9-49.e14.
pubmed: 27693658
doi: 10.1016/j.cmi.2016.09.022
Paling FP, Hazard D, Bonten MJM, Goossens H, Jafri HS, Malhotra-Kumar S, Sifakis F, Weber S, Kluytmans JAJW. Association of staphylococcus aureus colonization and pneumonia in the intensive care unit. JAMA Netw Open. 2020;3(9):e2012741.
pubmed: 32997125
pmcid: 7527877
doi: 10.1001/jamanetworkopen.2020.12741
Barbaro RP, Odetola FO, Kidwell KM, Paden ML, Bartlett RH, Davis MM, et al. Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry. Am J Respir Crit Care Med. 2015;191(8):894–901.
pubmed: 25695688
pmcid: 4435456
doi: 10.1164/rccm.201409-1634OC
Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–32.
pubmed: 18538699
doi: 10.1016/j.ajic.2008.03.002
Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1–45.
pubmed: 19489710
doi: 10.1086/599376
Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the infectious diseases society of America. Clin Infect Dis. 2010;50(5):625–63.
pubmed: 20175247
doi: 10.1086/650482
American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388–416.
doi: 10.1164/rccm.200405-644ST
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–10.
pubmed: 26903338
pmcid: 4968574
doi: 10.1001/jama.2016.0287
Heunks LM, van der Hoeven JG. Clinical review: the ABC of weaning failure–a structured approach. Crit Care Lond Engl. 2010;14(6):245.
doi: 10.1186/cc9296
Renard Trichè L, Futier E, De Carvalho M, Pinol-Domenech N, Bodet-Contentin L, Jabaudon M, et al. Sample size estimation in clinical trials using ventilator-free days as the primary outcome: a systematic review. Crit Care. 2023;27(1):303.
pubmed: 37528425
pmcid: 10394791
doi: 10.1186/s13054-023-04562-y
Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323–9.
pubmed: 19952319
doi: 10.1001/jama.2009.1754
Gupta R, Malik A, Rizvi M, Ahmed M, Singh A. Epidemiology of multidrug-resistant Gram-negative pathogens isolated from ventilator-associated pneumonia in ICU patients. J Glob Antimicrob Resist. 2017;9:47–50.
pubmed: 28288860
doi: 10.1016/j.jgar.2016.12.016
Bizzarro MJ, Conrad SA, Kaufman DA, Rycus P. Extracorporeal life support organization task force on infections, extracorporeal membrane oxygenation. Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2011;12(3):277–81.
Grasselli G, Scaravilli V, Alagna L, Bombino M, De Falco S, Bandera A, et al. Gastrointestinal colonization with multidrug-resistant Gram-negative bacteria during extracorporeal membrane oxygenation: effect on the risk of subsequent infections and impact on patient outcome. Ann Intensive Care. 2019;9(1):141.
pubmed: 31853672
pmcid: 6920277
doi: 10.1186/s13613-019-0615-7
Gao X, Wang W. The etiological and drug resistance characteristics of multidrug-resistant pathogens in patients requiring extracorporeal membrane oxygenation: a retrospective cohort study. Infect Drug Resist. 2023;16:4929–41.
pubmed: 37546369
pmcid: 10402724
doi: 10.2147/IDR.S421413
Aubron C, Cheng AC, Pilcher D, Leong T, Magrin G, Cooper DJ, et al. Infections acquired by adults who receive extracorporeal membrane oxygenation: risk factors and outcome. Infect Control Hosp Epidemiol. 2013;34(1):24–30.
pubmed: 23221189
doi: 10.1086/668439
Schmidt M, Bréchot N, Hariri S, Guiguet M, Luyt CE, Makri R, et al. Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation. Clin Infect Dis Off Publ Infect Dis Soc Am. 2012;55(12):1633–41.
doi: 10.1093/cid/cis783
Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol. 2009;30(12):1180–5.
pubmed: 19860564
pmcid: 2893218
doi: 10.1086/648451
Zhou HY, Yuan Z, Du YP. Prior use of four invasive procedures increases the risk of Acinetobacter baumannii nosocomial bacteremia among patients in intensive care units: a systematic review and meta-analysis. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2014;22:25–30.
Lankelma JM, van Vught LA, Belzer C, Schultz MJ, van der Poll T, de Vos WM, et al. Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study. Intensive Care Med. 2017;43(1):59–68.
pubmed: 27837233
doi: 10.1007/s00134-016-4613-z
Wolff NS, Hugenholtz F, Wiersinga WJ. The emerging role of the microbiota in the ICU. Crit Care Lond Engl. 2018;22(1):78.
doi: 10.1186/s13054-018-1999-8
Kao LS, Fleming GM, Escamilla RJ, Lew DF, Lally KP. Antimicrobial prophylaxis and infection surveillance in extracorporeal membrane oxygenation patients: a multi-institutional survey of practice patterns. ASAIO J. 2011;57(3):231–8.
pubmed: 21317768
doi: 10.1097/MAT.0b013e31820d19ab
Yusuf E, Bax HI, Verkaik NJ, van Westreenen M. An update on eight ‘new’ antibiotics against multidrug-resistant gram-negative bacteria. J Clin Med. 2021;10(5):1068.
pubmed: 33806604
pmcid: 7962006
doi: 10.3390/jcm10051068
Sherwin J, Heath T, Watt K. Pharmacokinetics and dosing of anti-infective drugs in patients on extracorporeal membrane oxygenation: a review of the current literature. Clin Ther. 2016;38(9):1976–94.
pubmed: 27553752
pmcid: 5535730
doi: 10.1016/j.clinthera.2016.07.169
Vogel AM, Lew DF, Kao LS, Lally KP. Defining risk for infectious complications on extracorporeal life support. J Pediatr Surg. 2011;46(12):2260–4.
pubmed: 22152861
doi: 10.1016/j.jpedsurg.2011.09.013
Sun HY, Ko WJ, Tsai PR, Sun CC, Chang YY, Lee CW, et al. Infections occurring during extracorporeal membrane oxygenation use in adult patients. J Thorac Cardiovasc Surg. 2010;140(5):1125-1132.e2.
pubmed: 20708754
doi: 10.1016/j.jtcvs.2010.07.017
Pieri M, Agracheva N, Fumagalli L, Greco T, De Bonis M, Calabrese MC, et al. Infections occurring in adult patients receiving mechanical circulatory support: the two-year experience of an Italian National Referral Tertiary Care Center. Med Intensiva. 2013;37(7):468–75.
pubmed: 23040766
doi: 10.1016/j.medin.2012.08.009
Cheng W, Chen J, Ma X, Sun J, Gao S, Wang Y, et al. Association between ICU quality and in-hospital mortality of V-V ECMO-supported patients-the ECMO quality improvement action (EQIA) study: a national cohort study in China from 2017 to 2019. Front Med. 2023;18(2):315–26.
pubmed: 37991709
doi: 10.1007/s11684-023-1014-x
Lemmen SW, Häfner H, Zolldann D, Stanzel S, Lütticken R. Distribution of multi-resistant gram-negative versus gram-positive bacteria in the hospital inanimate environment. J Hosp Infect. 2004;56(3):191–7.
pubmed: 15003666
doi: 10.1016/j.jhin.2003.12.004
Vincent JL, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, et al. Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA. 2020;323(15):1478–87.
pubmed: 32207816
pmcid: 7093816
doi: 10.1001/jama.2020.2717
Crivellari M, Pappalardo F. Femoro-jugular cannulation in veno-venous extracorporeal membrane oxygenation PRO/CON. J Thorac Dis. 2018;10(Suppl 5):S613–5.
pubmed: 29732178
pmcid: 5911552
doi: 10.21037/jtd.2018.02.89